# Cost Comparison Study of Darbepoetin Versus Epoetin Therapy to Treat Anemia in Hemodialysis Patients

> **NCT02817555** · PHASE4 · COMPLETED · sponsor: **Andrea L Woodland** · enrollment: 50 (actual)

## Conditions studied

- Anemia
- Chronic Kidney Disease

## Interventions

- **DRUG:** Epoetin Alfa
- **DRUG:** Darbepoetin alfa

## Key facts

- **NCT ID:** NCT02817555
- **Lead sponsor:** Andrea L Woodland
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2013-05
- **Final completion:** 2013-05
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02817555

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02817555, "Cost Comparison Study of Darbepoetin Versus Epoetin Therapy to Treat Anemia in Hemodialysis Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02817555. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*